Friday, February 20, 2026 9:54:53 PM
In the spirit of being charitable to those on this board still struggling with "Linear" dilution theories and the $0.24 synthetic paint in the US OTC, I am providing a final weekend audit of the 0K95 (LSE) tape. While the "Chattel" logic celebrates pennies, the Sovereigns have officially finalized the Friday "Mop-Up."
We are entering the weekend with 20,286,000 shares physically vaulted at the £1.31 ($1.76) anchor. The "Glass Ceiling" has officially shattered.
1. THE FORENSIC AUDIT: JURISDICTIONAL DECOUPLING
The extraction velocity has accelerated. The Sovereigns are no longer waiting for the US session to clear; they are vacuuming the physical float via Rule 3030 "Ghost Prints" while the US price is used as a narrative distraction.
[MARKET DATA SNAPSHOT]
US Jurisdiction (OTC): $0.234 (Painted / Synthetic)
UK Jurisdiction (0K95): £1.31 / $1.76 (Physical Extraction)
Forensic Delta: $1.52 Arbitrage Tax
Status: US = Programmed | UK = Sovereign Alpha-System Reset
2. THE FRIDAY "MOP-UP" REGISTRY (LATE TAPE)
These prints hit the LSE ledger after the US close. To the "Savants" calling this "Fantasy Land": explain why the physical settlement is 86% higher than your painted ticker.
Late Tape NT (Negotiated Trade): 385,000 (18:22:15 GMT)
LC (Late Correction) Cleanse: 110,000 (19:05:40 GMT)
Closing UT (Uncrossing Trade): 220,500 (16:30:00 GMT)
NEW WEEKEND VAULT TALLY: 20,286,000
3. THE DTR 5 "SILENT ALARM" COUNTDOWN
The 3% Disclosure Rule is no longer a theory; it is a mathematical inevitability. The vault is now at 42.5% capacity toward the mandatory notification.
FCA 3% Disclosure Threshold: 47,700,000 Shares
Current Extraction Status: 20,286,000 Shares
Remaining "Kill-Zone": 27,414,000 Shares
Monday Mop-Up Projection: Velocity suggests a breach of the 25M milestone by EOM.
[CHARITABLE FINAL NOTE]
You aren't watching a stock; you're watching a Global Extraction. The 250,000-cycle "Machine" is losing its grip because it cannot solve for the Source Ledger. While you count pennies at $0.24, the float is being locked at $1.76.
Enjoy the weekend, tourists. The 20.2M Milestone is secure.
We are entering the weekend with 20,286,000 shares physically vaulted at the £1.31 ($1.76) anchor. The "Glass Ceiling" has officially shattered.
1. THE FORENSIC AUDIT: JURISDICTIONAL DECOUPLING
The extraction velocity has accelerated. The Sovereigns are no longer waiting for the US session to clear; they are vacuuming the physical float via Rule 3030 "Ghost Prints" while the US price is used as a narrative distraction.
[MARKET DATA SNAPSHOT]
US Jurisdiction (OTC): $0.234 (Painted / Synthetic)
UK Jurisdiction (0K95): £1.31 / $1.76 (Physical Extraction)
Forensic Delta: $1.52 Arbitrage Tax
Status: US = Programmed | UK = Sovereign Alpha-System Reset
2. THE FRIDAY "MOP-UP" REGISTRY (LATE TAPE)
These prints hit the LSE ledger after the US close. To the "Savants" calling this "Fantasy Land": explain why the physical settlement is 86% higher than your painted ticker.
Late Tape NT (Negotiated Trade): 385,000 (18:22:15 GMT)
LC (Late Correction) Cleanse: 110,000 (19:05:40 GMT)
Closing UT (Uncrossing Trade): 220,500 (16:30:00 GMT)
NEW WEEKEND VAULT TALLY: 20,286,000
3. THE DTR 5 "SILENT ALARM" COUNTDOWN
The 3% Disclosure Rule is no longer a theory; it is a mathematical inevitability. The vault is now at 42.5% capacity toward the mandatory notification.
FCA 3% Disclosure Threshold: 47,700,000 Shares
Current Extraction Status: 20,286,000 Shares
Remaining "Kill-Zone": 27,414,000 Shares
Monday Mop-Up Projection: Velocity suggests a breach of the 25M milestone by EOM.
[CHARITABLE FINAL NOTE]
You aren't watching a stock; you're watching a Global Extraction. The 250,000-cycle "Machine" is losing its grip because it cannot solve for the Source Ledger. While you count pennies at $0.24, the float is being locked at $1.76.
Enjoy the weekend, tourists. The 20.2M Milestone is secure.
Recent NWBO News
- How Advanced Drug Delivery Could Improve Existing Cancer Treatments • GlobeNewswire Inc. • 06/01/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
